INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 274
- Registration Number
- NCT00790088
- Locations
- 🇧🇪
AZ Imelda, Bonheiden, Belgium
🇫🇷Centre Hospitalier de Haguenau, Haguenau, France
🇮🇹Sacco Hospital, University of Milan, Milan, Italy
SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Device: insulin pump with continuous glucose sensing (Paradigm Real-Time Insulin Pump System)Device: insulin pump and blinded continuous glucose sensing (Paradigm Real-Time insulin pump)
- First Posted Date
- 2008-01-22
- Last Posted Date
- 2019-09-16
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 153
- Registration Number
- NCT00598663
- Locations
- 🇩🇰
Glostrup Hospital, Glostrup, Denmark
🇳🇱Groene Hart Ziekenhuis, Gouda, Netherlands
🇩🇰Steno Diabetes Center, Copenhagen, Denmark
Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness
- Conditions
- Type 1 Diabetes
- Interventions
- Device: MiniMed Paradigm REAL-Time System
- First Posted Date
- 2007-09-17
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 29
- Registration Number
- NCT00530023
- Locations
- 🇺🇸
Portland Diabetes & Endocrinology, Portland, Oregon, United States
🇺🇸Diabetes Treatment Center, Loma Linda University, Loma Linda, California, United States
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
- Conditions
- Type 1 Diabetes
- Interventions
- Device: Minimed Paradigm 512/712 Insulin pumpDevice: Minimed paradigm Real Time Sytem
- First Posted Date
- 2007-02-28
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 115
- Registration Number
- NCT00441129
- Locations
- 🇫🇷
Hôpital Universitaire Debrousse, Lyon, France
🇫🇷Hôpital Sainte Marguerite, Marseille, France
🇫🇷CH La Peyronie, Montpellier, France
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
- Conditions
- Type 1 Diabetes
- Interventions
- Device: MiniMed Paradigm REAL-Time System
- First Posted Date
- 2007-01-04
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 485
- Registration Number
- NCT00417989
- Locations
- 🇺🇸
Scripps Institute, La Jolla, California, United States
🇺🇸Children's Hospital of Orange County (CHOC), Orange, California, United States
🇺🇸Barbara Davis Center, University of Colorado, Boulder, Colorado, United States
Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
- Conditions
- Type 1 Diabetes
- Interventions
- Drug: Medtronic MiniMed Implantable Pump Human Recombinant InsulinDevice: Medtronic MiniMed Implantable Pump SystemDrug: Aventis HOE21PH U400
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 107
- Registration Number
- NCT00211536
- Locations
- 🇺🇸
Sansum Medical Research Institute, Santa Barbara, California, United States
🇺🇸University of Colorado Health Sciences Center, Aurora, Colorado, United States
🇺🇸Hellman & Rosen Endocrine Associates, North Kansas City, Missouri, United States
Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes
- Conditions
- Type 1 Diabetes
- Interventions
- Device: Paradigm 722 sensor augmented pumpDevice: Paradigm 715 insulin pump
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 146
- Registration Number
- NCT00211510
- Locations
- 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸Atlanta Diabetes Associates, Atlanta, Georgia, United States
🇺🇸The Endocrine Group, Albany, New York, United States
The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT
- Conditions
- Diabetes Mellitus
- Interventions
- Device: Guardian RTDevice: SMBG only
- First Posted Date
- 2005-05-19
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Medtronic Diabetes
- Target Recruit Count
- 162
- Registration Number
- NCT00111228
- Locations
- 🇫🇷
CH Robert Debre, Paris, France
🇫🇷Hôpital Sud Francilien, Corbeil Esssonnes, France
🇩🇪Klinik für Allgemeine Charité, CVK, Berlin, Germany